Prevention and management of COPD in China: successes and major challenges

Lancet Respir Med. 2016 Jun;4(6):428-30. doi: 10.1016/S2213-2600(16)30092-3. Epub 2016 May 13.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Air Pollutants / adverse effects
  • Bronchodilator Agents / therapeutic use
  • China / epidemiology
  • Combined Modality Therapy
  • Disease Management*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Primary Prevention / methods*
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / prevention & control*
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Respiratory Therapy / methods
  • Risk Assessment
  • Severity of Illness Index
  • Smoking / adverse effects

Substances

  • Air Pollutants
  • Bronchodilator Agents